GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dian Diagnostics Group Co Ltd (SZSE:300244) » Definitions » Market Cap

Dian Diagnostics Group Co (SZSE:300244) Market Cap : ¥8,093 Mil (As of Jun. 08, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Dian Diagnostics Group Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Dian Diagnostics Group Co's share price for the quarter that ended in Mar. 2024 was ¥17.48. Dian Diagnostics Group Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 627 Mil. Therefore, Dian Diagnostics Group Co's market cap for the quarter that ended in Mar. 2024 was ¥10,958 Mil.

Dian Diagnostics Group Co's quarterly market cap increased from Sep. 2023 (¥14,732 Mil) to Dec. 2023 (¥14,926 Mil) but then declined from Dec. 2023 (¥14,926 Mil) to Mar. 2024 (¥10,958 Mil).

Dian Diagnostics Group Co's annual market cap declined from Dec. 2021 (¥20,829 Mil) to Dec. 2022 (¥15,754 Mil) and declined from Dec. 2022 (¥15,754 Mil) to Dec. 2023 (¥14,926 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Dian Diagnostics Group Co's Enterprise Value for Today is ¥9,767 Mil.


Dian Diagnostics Group Co Market Cap Historical Data

The historical data trend for Dian Diagnostics Group Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dian Diagnostics Group Co Market Cap Chart

Dian Diagnostics Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13,730.74 21,269.30 20,828.78 15,753.95 14,926.44

Dian Diagnostics Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17,960.63 16,067.40 14,732.10 14,926.44 10,958.18

Competitive Comparison of Dian Diagnostics Group Co's Market Cap

For the Diagnostics & Research subindustry, Dian Diagnostics Group Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dian Diagnostics Group Co's Market Cap Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dian Diagnostics Group Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Dian Diagnostics Group Co's Market Cap falls into.



Dian Diagnostics Group Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Dian Diagnostics Group Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥23.81*626.898
=¥14,926

Dian Diagnostics Group Co's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=¥17.48*626.898
=¥10,958

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dian Diagnostics Group Co  (SZSE:300244) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Dian Diagnostics Group Co Market Cap Related Terms

Thank you for viewing the detailed overview of Dian Diagnostics Group Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Dian Diagnostics Group Co (SZSE:300244) Business Description

Traded in Other Exchanges
N/A
Address
No. 329, Jinpeng Street, 5th Floor, Building 2, Xihu District, Zhejiang, Hangzhou, CHN, 310030
Dian Diagnostics Group Co Ltd is an independent third-party medical diagnostic service provider that provides diagnostic services outsourcing as its core business. It promotes the development of multi-service areas of medical diagnostic platforms and integrated development strategies for upstream and downstream industry chains, covering medical diagnostic services and diagnostic products.
Executives
Chen Hai Bin Director
Chen Shi Shi Supervisors
Guo San Hui Executives
Yao Shu Lie Executives
Xu Min Director
Wang Yan Xiao Directors, executives
Chen Zuo Xiu Directors, executives
Hu Yong Director
Hu Miao Shen Executives
Chen Xue Dong Director
Jiang Tang Directors, executives
Tao Jun Securities Affairs Representative
Wu Zheng Xin Executives
Cheng Xiu Li Supervisors

Dian Diagnostics Group Co (SZSE:300244) Headlines

No Headlines